Drugs / 2S, 4R Ketoconazole
2S, 4R Ketoconazole
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00302224 | Feb 2005 → Aug 2006 | type 2 diabetes mellitus | DiObex | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 2S, 4R Ketoconazole | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00302224 ↗ |
| Known as | 2S,4R Enantiomer of Ketoconazole | “2S,4R Enantiomer of Ketoconazole (DIO-902)” NCT00302224 ↗ |
| Known as | DIO-902 | “2S,4R Enantiomer of Ketoconazole (DIO-902)” NCT00302224 ↗ |
| Route | Oral | “14 Days of Oral Dosing” NCT00302224 ↗ |